QQ客服 官方微博 反馈留言

浏览/检索结果: 共5条，第1-5条 帮助 限定条件 专题：复旦大学上海医学院    第一署名单位    第一作者单位    通讯作者单位     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 CMAB009 plus irinotecan versus irinotecan-only as second-line treatment after fluoropyrimidine and oxaliplatin failure in KRAS wild-type metastatic colorectal cancer patients: promising findings from a prospective, open-label, randomized, phase III trial 期刊论文 CANCER COMMUNICATIONS, 2019, 卷号: 39 作者:  Shi, Yuankai;  Li, Jin;  Xu, Jianming;  Sun, Yan;  Wang, Liwei 收藏  |  浏览/下载：114/0  |  提交时间：2019/12/05 CMAB009  Cetuximab  Irinotecan  Second-line  mCRC  EGFR  KRAS  Immunogenicity  Fluoropyrimidine  Oxaliplatin failure   A phase III trial (ZJBIO009): CMAB009 plus irinotecan versus irinotecan alone as second-line treatment after fluoropyrimidine and oxaliplatin failure in wild-type K-ras metastatic colorectal cancer patients 期刊论文 Journal of Clinical Oncology, 2017, 卷号: 35 作者:  Shi Y., Li J., Xu J., Cheng Y., Liu W., Cheng Y., Bai L., Zhang Y., He X., Luo Y., Liu Y., Yao Q., Li Y., Qin S., Hu X., Guo Y., Sun Y. 收藏  |  浏览/下载：8/0  |  提交时间：2019/12/05 Capecitabine "metronomic" chemotherapy for palliative treatment of elderly patients with advanced gastric cancer after fluoropyrimidine-based chemotherapy 期刊论文 MEDICAL ONCOLOGY, 2012, 卷号: 29, 期号: 1 作者:  He, ShengLi;  Shen, Jie;  Hong, Liang;  Niu, LuMing;  Niu, DaoYong 收藏  |  浏览/下载：1/0  |  提交时间：2019/12/19 Metronomic chemotherapy  Advanced gastric cancer  Capecitabine  Elderly patients   Transfection of thymidine phosphorylase cDNA to human hepatocellular carcinoma cells enhances sensitivity to fluoropyrimidine but augments endothelial cell migration 期刊论文 JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2005, 卷号: 131, 期号: 8 作者:  Zhou, J;  Xiao, YS;  Tang, ZY;  Fan, J;  Wu, ZQ 收藏  |  浏览/下载：3/0  |  提交时间：2019/12/27 thymidine phosphorylase  hepatocellular carcinoma  fluoropyrimidine  angiogenesis   Multicenter phase II study of modified FOLFIRI in patients in a Chinese population with advanced colorectal cancer (CRC) refractory to fluoropyrimidine and oxaliplatin. 会议论文 作者:  Zhang, W;  Zhao, ZY;  Nu, Q;  Li, J;  Fu, Q 收藏  |  浏览/下载：3/0  |  提交时间：2019/12/27